Family members said, more than once on Friday, that Frontotemporal Dementia (FTD) is the other dementia few doctors mention when patients come in describing cognitive changes. Usually the diagnosis is “Alzheimer's” or normal aging, Parkinson’s, vascular dementia, or mini-strokes. Sometimes it’s depression, or bipolar disease.
The Annual Education Conference 2017 of the Association for Frontotemporal Degeneration (AFTD) held May 5 in Baltimore shed some light on the disease and offered support to those affected by FTD. Dr. Chiadi Onyike, a neuropsychiatrist and associate professor of Psychiatry and Behavioral Sciences at John Hopkins University, and director of the Johns Hopkins Frontotemporal Dementia and Young-Onset Dementias Program, talked about the symptoms of frontotemporal disorders, which gradually take away basic abilities: talking, walking, socializing — often striking people in middle age, when they are working and raising families.
According to the NIH, scientists believe FTD (Frontotemporal Dementia) may cause up to 10 percent of all cases of dementia. Roughly 60 percent of people with FTLD (the collective term for frontotemporal lobar degeneration) are 45-64 years old. There are three types of disorders: progressive behavior/personality decline; progressive language decline; and progressive motor decline. The disease has a genetic component in about 40 percent of cases, but more often the incidence is sporadic.
Onyike told the group of about 400 people that frontotemporal disorders are the result of damage to neurons in parts of the brain called the frontal and temporal lobes. As neurons die in those regions, the lobes atrophy or shrink. Unusual behaviors, emotional problems, trouble communicating, difficulty walking, or issues at work can occur. Clumsiness, neuromuscular weakness, the inability to find words, apathy and lack of empathy, and social-interpersonal changes are just some of the the symptoms that can appear in FTD cases. Their memories, however, appear more or less intact, and they enjoy activities, sometimes new activities they haven’t learned before.
Speakers at the conference acknowledged it is hard to diagnose FTD, but it is becoming easier thanks to ongoing research. A brain autopsy is the most definitive way to diagnose which kind of FTLD the patient has: loss of neurons and abnormal amounts of proteins called “tau” and TDP-43” accumulation in the FTLD neurons, for instance, tell the story clearly. If someone believes they or a family member has FTD, according to NIH, the best way to diagnose the disease in a living person is to record symptoms, put together a personal and family medical history, undergo a physical exam with blood tests, conduct a neuropsychological evaluation to assess cognitive functions, obtain brain imaging to look for changes in the frontal and temporal lobes, and go to someone who knows what FTLD looks like.
Speakers at the conference also noted research has now uncovered several different genes that, when mutated, can lead to frontotemporal disorders. Environmental factors that may influence risk for developing the disorders are also being researched. Families affected by inherited and familial forms of FTD can help research progress by participating in clinical studies and trials. The AFTD works to support families affected by the disease and to suggest useful therapies and strategies for communication.
Locally, resources for FTD are growing, but still nascent. Arden Courts Memory Care Community is offering a free dementia education seminar on May 9 from 2-3:30 p.m. at the Radisson North Baltimore, 2004 Greenspring Drive, Timonium, Md. AFTD runs FTD caregiver support groups in the Middle Atlantic Region, the closest of which to Northern Virginia is at the Arden Courts Kensington, in Kensington, Md. Contact Elaine Rose at errose36@gmail.com for information.
In addition, if a diagnosis is still pending and it may be the “other” dementia, attendees at the AFTD conference agreed the Johns Hopkins FTD Clinic was the best nearby location for diagnosis, or see a neuropsychiatrist or a neurologist who is conversant with the disease.
AFTD is looking for volunteers, research participants, and funds: see www. https://www.theaftd.org/get-involved/ways-to-give/electronically or www.theaftd.org/get-involved/volunteer.